THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 113 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,967,066 | -1.1% | 575,558 | +18.6% | 0.00% | 0.0% |
| Q2 2023 | $5,024,046 | -73.9% | 485,415 | -72.7% | 0.00% | -50.0% |
| Q1 2023 | $19,269,230 | +95.8% | 1,775,966 | +102.4% | 0.00% | +100.0% |
| Q4 2022 | $9,843,026 | +5.4% | 877,275 | -4.8% | 0.00% | 0.0% |
| Q3 2022 | $9,342,000 | +52.6% | 921,281 | +36.4% | 0.00% | 0.0% |
| Q2 2022 | $6,121,000 | -4.3% | 675,633 | +1.0% | 0.00% | 0.0% |
| Q1 2022 | $6,395,000 | +1210.5% | 668,896 | +1412.7% | 0.00% | – |
| Q4 2021 | $488,000 | +24.2% | 44,220 | -16.8% | 0.00% | – |
| Q3 2021 | $393,000 | -62.2% | 53,139 | -25.8% | 0.00% | – |
| Q2 2021 | $1,040,000 | -50.2% | 71,576 | -30.0% | 0.00% | – |
| Q1 2021 | $2,087,000 | +43.9% | 102,213 | +25.2% | 0.00% | – |
| Q4 2020 | $1,450,000 | +40.9% | 81,634 | +17.4% | 0.00% | – |
| Q3 2020 | $1,029,000 | -46.6% | 69,564 | -24.3% | 0.00% | – |
| Q2 2020 | $1,928,000 | +46.1% | 91,838 | +60.8% | 0.00% | – |
| Q1 2020 | $1,320,000 | +126.0% | 57,118 | +153.4% | 0.00% | – |
| Q4 2019 | $584,000 | -17.2% | 22,540 | -37.8% | 0.00% | – |
| Q3 2019 | $705,000 | +79.8% | 36,211 | +50.7% | 0.00% | – |
| Q2 2019 | $392,000 | -25.6% | 24,030 | +3.3% | 0.00% | – |
| Q1 2019 | $527,000 | +7.1% | 23,264 | +21.0% | 0.00% | – |
| Q4 2018 | $492,000 | +48.6% | 19,233 | +89.4% | 0.00% | – |
| Q3 2018 | $331,000 | -60.5% | 10,156 | -72.5% | 0.00% | – |
| Q2 2018 | $838,000 | -3.9% | 36,932 | +2.7% | 0.00% | – |
| Q1 2018 | $872,000 | -7.1% | 35,978 | +6.8% | 0.00% | – |
| Q4 2017 | $939,000 | -67.2% | 33,683 | -59.7% | 0.00% | – |
| Q3 2017 | $2,866,000 | +136.7% | 83,684 | +175.3% | 0.00% | – |
| Q2 2017 | $1,211,000 | -58.3% | 30,394 | -61.4% | 0.00% | -100.0% |
| Q1 2017 | $2,902,000 | -13.6% | 78,821 | -25.1% | 0.00% | 0.0% |
| Q4 2016 | $3,357,000 | -15.7% | 105,300 | -4.2% | 0.00% | 0.0% |
| Q3 2016 | $3,982,000 | +41.8% | 109,868 | -11.3% | 0.00% | 0.0% |
| Q2 2016 | $2,809,000 | +41.0% | 123,807 | +16.8% | 0.00% | – |
| Q1 2016 | $1,992,000 | +5.3% | 106,017 | -8.1% | 0.00% | – |
| Q4 2015 | $1,891,000 | +42.4% | 115,392 | -4.5% | 0.00% | – |
| Q3 2015 | $1,328,000 | +17.5% | 120,792 | +39.1% | 0.00% | – |
| Q2 2015 | $1,130,000 | -20.5% | 86,821 | +5.9% | 0.00% | – |
| Q1 2015 | $1,422,000 | -3.0% | 81,990 | -16.5% | 0.00% | -100.0% |
| Q4 2014 | $1,466,000 | -53.9% | 98,210 | -28.8% | 0.00% | 0.0% |
| Q3 2014 | $3,181,000 | -43.6% | 137,993 | -22.1% | 0.00% | -50.0% |
| Q2 2014 | $5,644,000 | – | 177,058 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |